The US government is being urged to take action over soaring insulin prices in America.

The average price of insulin has nearly tripled between 2002 and 2013, making accessing insulin very difficult for many Americans with diabetes.

The American Medical Association (AMA) is calling on the Federal Trade Commission and the Justice Department to start lowering the price of insulin and monitor market competition in a bid to keep a tighter control of increasing costs.